Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has signed a distribution agreement with one of the Top 10 US medical
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Data set of 2 billion heartbeats and growing allows Biotricity to scale faster and operate more efficiently with better automation, yielding growth and better margins in the future
Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 22.73 percent. The company reported quarterly sales of $2.10 million which missed the